KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Progyny (PGNY) Liabilities and Shareholders Equity (2018 - 2025)

Historic Liabilities and Shareholders Equity for Progyny (PGNY) over the last 8 years, with Q3 2025 value amounting to $795.2 million.

  • Progyny's Liabilities and Shareholders Equity rose 2049.41% to $795.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.9 billion, marking a year-over-year increase of 629.01%. This contributed to the annual value of $607.1 million for FY2024, which is 1976.13% down from last year.
  • As of Q3 2025, Progyny's Liabilities and Shareholders Equity stood at $795.2 million, which was up 2049.41% from $760.9 million recorded in Q2 2025.
  • Progyny's 5-year Liabilities and Shareholders Equity high stood at $795.2 million for Q3 2025, and its period low was $294.6 million during Q1 2021.
  • For the 5-year period, Progyny's Liabilities and Shareholders Equity averaged around $574.0 million, with its median value being $607.1 million (2024).
  • In the last 5 years, Progyny's Liabilities and Shareholders Equity surged by 7576.34% in 2021 and then plummeted by 1976.13% in 2024.
  • Over the past 5 years, Progyny's Liabilities and Shareholders Equity (Quarter) stood at $358.1 million in 2021, then surged by 51.64% to $543.0 million in 2022, then surged by 39.34% to $756.6 million in 2023, then dropped by 19.76% to $607.1 million in 2024, then skyrocketed by 30.99% to $795.2 million in 2025.
  • Its Liabilities and Shareholders Equity stands at $795.2 million for Q3 2025, versus $760.9 million for Q2 2025 and $730.3 million for Q1 2025.